{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T01:23:33Z","timestamp":1793582613811,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG072298"],"award-info":[{"award-number":["R01AG072298"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS110776"],"award-info":[{"award-number":["R01NS110776"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS110776"],"award-info":[{"award-number":["R01NS110776"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AT012707"],"award-info":[{"award-number":["R01AT012707"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AT011439"],"award-info":[{"award-number":["R01AT011439"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CNS2, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"DOI":"10.1038\/s41587-026-03185-2","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:03:10Z","timestamp":1783501390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficient targeting of human glial progenitor cells in vivo with engineered AAV vectors and glymphatic delivery"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8065-9414","authenticated-orcid":false,"given":"Alexander","family":"Cona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Newbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Kesmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2511-8665","authenticated-orcid":false,"given":"Rajiv","family":"Snape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Danner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9012-7535","authenticated-orcid":false,"given":"Nicholas","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Borden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6054-5962","authenticated-orcid":false,"given":"Abigail","family":"Iseson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Schanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Chandler-Militello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose C.","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiken","family":"Nedergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdellatif","family":"Benraiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5498-4303","authenticated-orcid":false,"given":"Steven A.","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"3185_CR1","doi-asserted-by":"publisher","first-page":"a041371","DOI":"10.1101\/cshperspect.a041371","volume":"16","author":"RJM Franklin","year":"2024","unstructured":"Franklin, R. J. M., Bodini, B. & Goldman, S. A. Remyelination in the central nervous system. Cold Spring Harb. Perspect. Biol. 16, a041371 (2024).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"3185_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neuron.2024.10.019","volume":"113","author":"J Groh","year":"2025","unstructured":"Groh, J. & Simons, M. White matter aging and its impact on brain function. Neuron 113, 127\u2013139 (2025).","journal-title":"Neuron"},{"key":"3185_CR3","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1093\/brain\/awae166","volume":"147","author":"NPT Huynh","year":"2024","unstructured":"Huynh, N. P. T. et al. Shared patterns of glial transcriptional dysregulation link Huntington\u2019s disease and schizophrenia. Brain 147, 3099\u20133112 (2024).","journal-title":"Brain"},{"key":"3185_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.stem.2018.11.010","volume":"24","author":"M Osipovitch","year":"2019","unstructured":"Osipovitch, M. et al. Human ESC-derived chimeric mouse models of Huntington\u2019s disease reveal cell-intrinsic defects in glial progenitor cell differentiation. Cell Stem Cell 24, 107\u2013122 (2019).","journal-title":"Cell Stem Cell"},{"key":"3185_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.stem.2017.06.012","volume":"21","author":"MS Windrem","year":"2017","unstructured":"Windrem, M. S. et al. Human iPSC glial mouse chimeras reveal glial contributions to schizophrenia. Cell Stem Cell 21, 195\u2013208 (2017).","journal-title":"Cell Stem Cell"},{"key":"3185_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3440","volume":"34","author":"BE Deverman","year":"2016","unstructured":"Deverman, B. E. et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat. Biotechnol. 34, 204\u2013209 (2016).","journal-title":"Nat. Biotechnol."},{"key":"3185_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41592-020-0799-7","volume":"17","author":"SR Kumar","year":"2020","unstructured":"Kumar, S. R. et al. Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types. Nat. Methods 17, 541\u2013550 (2020).","journal-title":"Nat. Methods"},{"key":"3185_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1435212","volume":"18","author":"J Giacomoni","year":"2024","unstructured":"Giacomoni, J. et al. Identification and validation of novel engineered AAV capsid variants targeting human glia. Front. Neurosci. 18, 1435212 (2024).","journal-title":"Front. Neurosci."},{"key":"3185_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/gt.2016.62","volume":"23","author":"SK Powell","year":"2016","unstructured":"Powell, S. K. et al. Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism. Gene Ther. 23, 807\u2013814 (2016).","journal-title":"Gene Ther."},{"key":"3185_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0451-7","volume":"5","author":"RJ Mandel","year":"2017","unstructured":"Mandel, R. J. et al. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates. Acta Neuropathol. Commun. 5, 47 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"3185_CR11","doi-asserted-by":"publisher","first-page":"9986","DOI":"10.1523\/JNEUROSCI.19-22-09986.1999","volume":"19","author":"NS Roy","year":"1999","unstructured":"Roy, N. S. et al. Identification, isolation, and promoter-defined separation of mitotic oligodendrocyte progenitor cells from the adult human subcortical white matter. J. Neurosci. 19, 9986\u20139995 (1999).","journal-title":"J. Neurosci."},{"key":"3185_CR12","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/brain\/121.12.2221","volume":"121","author":"N Scolding","year":"1998","unstructured":"Scolding, N. et al. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 121, 2221\u20132228 (1998).","journal-title":"Brain"},{"key":"3185_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0306-4522(98)00548-X","volume":"89","author":"NJ Scolding","year":"1999","unstructured":"Scolding, N. J., Rayner, P. J. & Compston, D. A. Identification of A2B5-positive putative oligodendrocyte progenitor cells and A2B5-positive astrocytes in adult human white matter. Neuroscience 89, 1\u20134 (1999).","journal-title":"Neuroscience"},{"key":"3185_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nm974","volume":"10","author":"MS Windrem","year":"2004","unstructured":"Windrem, M. S. et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat. Med. 10, 93\u201397 (2004).","journal-title":"Nat. Med."},{"key":"3185_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nm837","volume":"9","author":"MC Nunes","year":"2003","unstructured":"Nunes, M. C. et al. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat. Med. 9, 439\u2013447 (2003).","journal-title":"Nat. Med."},{"key":"3185_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002112","volume":"21","author":"Q Huang","year":"2023","unstructured":"Huang, Q. et al. Targeting AAV vectors to the central nervous system by engineering capsid-receptor interactions that enable crossing of the blood\u2013brain barrier. PLoS Biol. 21, e3002112 (2023).","journal-title":"PLoS Biol."},{"key":"3185_CR17","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.adm8386","volume":"384","author":"Q Huang","year":"2024","unstructured":"Huang, Q. et al. An AAV capsid reprogrammed to bind human transferrin receptor mediates brain-wide gene delivery. Science 384, 1220\u20131227 (2024).","journal-title":"Science"},{"key":"3185_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225206","volume":"14","author":"Q Huang","year":"2019","unstructured":"Huang, Q. et al. Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids. PLoS ONE 14, e0225206 (2019).","journal-title":"PLoS ONE"},{"key":"3185_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/hum.2018.015","volume":"29","author":"C Hinderer","year":"2018","unstructured":"Hinderer, C. et al. Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN. Hum. Gene Ther. 29, 285\u2013298 (2018).","journal-title":"Hum. Gene Ther."},{"key":"3185_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s40259-023-00585-7","volume":"37","author":"M Arjomandnejad","year":"2023","unstructured":"Arjomandnejad, M., Dasgupta, I., Flotte, T. R. & Keeler, A. M. Immunogenicity of recombinant adeno-associated virus (AAV) vectors for gene transfer. BioDrugs 37, 311\u2013329 (2023).","journal-title":"BioDrugs"},{"key":"3185_CR21","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1016\/j.ymthe.2023.10.015","volume":"31","author":"D Duan","year":"2023","unstructured":"Duan, D. Lethal immunotoxicity in high-dose systemic AAV therapy. Mol. Ther. 31, 3123\u20133126 (2023).","journal-title":"Mol. Ther."},{"key":"3185_CR22","doi-asserted-by":"publisher","first-page":"8S46","DOI":"10.1016\/S0929-693X(23)00227-0","volume":"30","author":"A Gardin","year":"2023","unstructured":"Gardin, A. & Ronzitti, G. Current limitations of gene therapy for rare pediatric diseases: lessons learned from clinical experience with AAV vectors. Arch. Pediatr. 30, 8S46\u201348S52 (2023).","journal-title":"Arch. Pediatr."},{"key":"3185_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2023.08.021","volume":"31","author":"Y Guo","year":"2023","unstructured":"Guo, Y. et al. High-titer AAV disrupts cerebrovascular integrity and induces lymphocyte infiltration in adult mouse brain. Mol. Ther. Methods Clin. Dev. 31, 101102 (2023).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"3185_CR24","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41573-023-00766-7","volume":"22","author":"Q Ling","year":"2023","unstructured":"Ling, Q., Herstine, J. A., Bradbury, A. & Gray, S. J. AAV-based in vivo gene therapy for neurological disorders. Nat. Rev. Drug Discov. 22, 789\u2013806 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"3185_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff, J. J. et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci. Transl. Med. 4, 147ra111 (2012).","journal-title":"Sci. Transl. Med."},{"key":"3185_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jconrel.2023.01.054","volume":"355","author":"TO Lilius","year":"2023","unstructured":"Lilius, T. O. et al. Glymphatic-assisted perivascular brain delivery of intrathecal small gold nanoparticles. J. Control. Release 355, 135\u2013148 (2023).","journal-title":"J. Control. Release"},{"key":"3185_CR27","doi-asserted-by":"publisher","first-page":"e120922","DOI":"10.1172\/jci.insight.120922","volume":"3","author":"BA Plog","year":"2018","unstructured":"Plog, B. A. et al. Transcranial optical imaging reveals a pathway for optimizing the delivery of immunotherapeutics to the brain. JCI Insight 3, e120922 (2018).","journal-title":"JCI Insight"},{"key":"3185_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2019.108441","volume":"328","author":"G Wu","year":"2019","unstructured":"Wu, G. et al. The glymphatic system delivery enhances the transduction efficiency of AAV1 to brain endothelial cells in adult mice. J. Neurosci. Methods 328, 108441 (2019).","journal-title":"J. Neurosci. Methods"},{"key":"3185_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2020.146832","volume":"1739","author":"RM Bailey","year":"2020","unstructured":"Bailey, R. M., Rozenberg, A. & Gray, S. J. Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies. Brain Res. 1739, 146832 (2020).","journal-title":"Brain Res."},{"key":"3185_CR30","first-page":"e57378","volume":"135","author":"ALR Xavier","year":"2018","unstructured":"Xavier, A. L. R. et al. Cannula implantation into the cisterna magna of rodents. J. Vis. Exp. 135, e57378 (2018).","journal-title":"J. Vis. Exp."},{"key":"3185_CR31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ymthe.2019.11.012","volume":"28","author":"T Taghian","year":"2020","unstructured":"Taghian, T. et al. A safe and reliable technique for CNS delivery of AAV vectors in the cisterna magna. Mol. Ther. 28, 411\u2013421 (2020).","journal-title":"Mol. Ther."},{"key":"3185_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau9859","volume":"4","author":"MJ Castle","year":"2018","unstructured":"Castle, M. J., Cheng, Y., Asokan, A. & Tuszynski, M. H. Physical positioning markedly enhances brain transduction after intrathecal AAV9 infusion. Sci. Adv. 4, eaau9859 (2018).","journal-title":"Sci. Adv."},{"key":"3185_CR33","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/nbt.1972","volume":"29","author":"FJ Sim","year":"2011","unstructured":"Sim, F. J. et al. CD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cells. Nat. Biotechnol. 29, 934\u2013941 (2011).","journal-title":"Nat. Biotechnol."},{"key":"3185_CR34","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR\u2013Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"3185_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.stem.2012.12.002","volume":"12","author":"S Wang","year":"2013","unstructured":"Wang, S. et al. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 12, 252\u2013264 (2013).","journal-title":"Cell Stem Cell"},{"key":"3185_CR36","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.stem.2008.03.020","volume":"2","author":"MS Windrem","year":"2008","unstructured":"Windrem, M. S. et al. Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Cell Stem Cell 2, 553\u2013565 (2008).","journal-title":"Cell Stem Cell"},{"key":"3185_CR37","doi-asserted-by":"publisher","first-page":"16153","DOI":"10.1523\/JNEUROSCI.1510-14.2014","volume":"34","author":"MS Windrem","year":"2014","unstructured":"Windrem, M. S. et al. A competitive advantage by neonatally engrafted human glial progenitors yields mice whose brains are chimeric for human glia. J. Neurosci. 34, 16153\u201316161 (2014).","journal-title":"J. Neurosci."},{"key":"3185_CR38","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S1474-4422(15)00221-5","volume":"14","author":"JJ Iliff","year":"2015","unstructured":"Iliff, J. J., Goldman, S. A. & Nedergaard, M. Implications of the discovery of brain lymphatic pathways. Lancet Neurol. 14, 977\u2013979 (2015).","journal-title":"Lancet Neurol."},{"key":"3185_CR39","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/jgm.686","volume":"7","author":"JP Louboutin","year":"2005","unstructured":"Louboutin, J. P., Wang, L. & Wilson, J. M. Gene transfer into skeletal muscle using novel AAV serotypes. J. Gene Med. 7, 442\u2013451 (2005).","journal-title":"J. Gene Med."},{"key":"3185_CR40","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.neuron.2016.09.021","volume":"92","author":"DG Tervo","year":"2016","unstructured":"Tervo, D. G. et al. A designer AAV variant permits efficient retrograde access to projection neurons. Neuron 92, 372\u2013382 (2016).","journal-title":"Neuron"},{"key":"3185_CR41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-1-4939-3271-9_10","volume":"1382","author":"MJ Castle","year":"2016","unstructured":"Castle, M. J., Turunen, H. T., Vandenberghe, L. H. & Wolfe, J. H. Controlling AAV tropism in the nervous system with natural and engineered capsids. Methods Mol. Biol. 1382, 133\u2013149 (2016).","journal-title":"Methods Mol. Biol."},{"key":"3185_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.omtn.2022.03.017","volume":"28","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Directed evolution of adeno-associated virus 5 capsid enables specific liver tropism. Mol. Ther. Nucleic Acids 28, 293\u2013306 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"3185_CR43","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nbt811","volume":"21","author":"F Schnutgen","year":"2003","unstructured":"Schnutgen, F. et al. A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse. Nat. Biotechnol. 21, 562\u2013565 (2003).","journal-title":"Nat. Biotechnol."},{"key":"3185_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107658","volume":"31","author":"MS Windrem","year":"2020","unstructured":"Windrem, M. S. et al. Human glial progenitor cells effectively remyelinate the demyelinated adult brain. Cell Rep. 31, 107658 (2020).","journal-title":"Cell Rep."},{"key":"3185_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nn1162","volume":"7","author":"SC Lin","year":"2004","unstructured":"Lin, S. C. & Bergles, D. E. Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus. Nat. Neurosci. 7, 24\u201332 (2004).","journal-title":"Nat. Neurosci."},{"key":"3185_CR46","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1523\/JNEUROSCI.6000-09.2010","volume":"30","author":"LM de Biase","year":"2010","unstructured":"de Biase, L. M., Nishiyama, A. & Bergles, D. E. Excitability and synaptic communication within the oligodendrocyte lineage. J. Neurosci. 30, 3600\u20133611 (2010).","journal-title":"J. Neurosci."},{"key":"3185_CR47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1083\/jcb.200210110","volume":"161","author":"S Belachew","year":"2003","unstructured":"Belachew, S. et al. Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J. Cell Biol. 161, 169\u2013186 (2003).","journal-title":"J. Cell Biol."},{"key":"3185_CR48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abb8739","volume":"370","author":"M Nedergaard","year":"2020","unstructured":"Nedergaard, M. & Goldman, S. A. Glymphatic failure as a final common pathway to dementia. Science 370, 50\u201356 (2020).","journal-title":"Science"},{"key":"3185_CR49","doi-asserted-by":"publisher","unstructured":"Mich, J.K., et al. Enhancer-AAVs allow genetic access to oligodendrocytes and diverse populations of astrocytes across species. eLife https:\/\/doi.org\/10.7554\/eLife.108640.1 (2025).","DOI":"10.7554\/eLife.108640.1"},{"key":"3185_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1248271","volume":"16","author":"EA Salegio","year":"2023","unstructured":"Salegio, E. A., Hancock, K. & Korszen, S. Pre-clinical delivery of gene therapy products to the cerebrospinal fluid: challenges and considerations for clinical translation. Front. Mol. Neurosci. 16, 1248271 (2023).","journal-title":"Front. Mol. Neurosci."},{"key":"3185_CR51","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1089\/hum.2022.163","volume":"34","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Biodistribution of adeno-associated virus gene therapy following cerebrospinal fluid-directed administration. Hum. Gene Ther. 34, 94\u2013111 (2023).","journal-title":"Hum. Gene Ther."},{"key":"3185_CR52","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.88034","volume":"1","author":"G Murlidharan","year":"2016","unstructured":"Murlidharan, G., Crowther, A., Reardon, R. A., Song, J. & Asokan, A. Glymphatic fluid transport controls paravascular clearance of AAV vectors from the brain. JCI Insight 1, e88034 (2016).","journal-title":"JCI Insight"},{"key":"3185_CR53","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ccr.2010.10.033","volume":"18","author":"AI Persson","year":"2010","unstructured":"Persson, A. I. et al. Non-stem cell origin for oligodendroglioma. Cancer Cell 18, 669\u2013682 (2010).","journal-title":"Cancer Cell"},{"key":"3185_CR54","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","volume":"618","author":"C Depp","year":"2023","unstructured":"Depp, C. et al. Myelin dysfunction drives amyloid-\u03b2 deposition in models of Alzheimer\u2019s disease. Nature 618, 349\u2013357 (2023).","journal-title":"Nature"},{"key":"3185_CR55","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41593-022-01104-7","volume":"25","author":"M Kenigsbuch","year":"2022","unstructured":"Kenigsbuch, M. et al. A shared disease-associated oligodendrocyte signature among multiple CNS pathologies. Nat. Neurosci. 25, 876\u2013886 (2022).","journal-title":"Nat. Neurosci."},{"key":"3185_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0515-3","volume":"6","author":"SE Nasrabady","year":"2018","unstructured":"Nasrabady, S. E., Rizvi, B., Goldman, J. E. & Brickman, A. M. White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol. Commun. 6, 22 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"3185_CR57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/nyas.14372","volume":"1471","author":"SA Goldman","year":"2020","unstructured":"Goldman, S. A. Glial evolution as a determinant of human behavior and its disorders. Ann. N. Y. Acad. Sci. 1471, 72\u201385 (2020).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"3185_CR58","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41587-023-01798-5","volume":"42","author":"R Vieira","year":"2024","unstructured":"Vieira, R. et al. Young glial progenitor cells competitively replace aged and diseased human glia in the adult chimeric mouse brain. Nat. Biotechnol. 42, 719\u2013730 (2024).","journal-title":"Nat. Biotechnol."},{"key":"3185_CR59","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41596-018-0097-3","volume":"14","author":"RC Challis","year":"2019","unstructured":"Challis, R. C. et al. Systemic AAV vectors for widespread and targeted gene delivery in rodents. Nat. Protoc. 14, 379\u2013414 (2019).","journal-title":"Nat. Protoc."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03185-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03185-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03185-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:03:11Z","timestamp":1783501391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03185-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":59,"alternative-id":["3185"],"URL":"https:\/\/doi.org\/10.1038\/s41587-026-03185-2","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.A.G. and M.N. are cofounders and scientific advisory board members of CNS2, Inc.; their labs also receive research support from CNS2. A.B. has equity in CNS2. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}